Where are we going with regional therapy for melanoma?
Tyler
Douglas
D
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D002986:Clinical Trials as Topic; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D010166:Palliative Care; D018579:Patient Selection; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha